Millennium Management’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-13,501
| Closed | -$8K | – | 6336 |
|
|
2022
Q2 | $8K | Sell |
13,501
-77,208
| -85% | -$45.8K | ﹤0.01% | 5014 |
|
|
2022
Q1 | $120K | Sell |
90,709
-39,619
| -30% | -$52.4K | ﹤0.01% | 4807 |
|
|
2021
Q4 | $340K | Sell |
130,328
-169,488
| -57% | -$442K | ﹤0.01% | 4304 |
|
|
2021
Q3 | $932K | Buy |
299,816
+92,273
| +44% | +$287K | ﹤0.01% | 3717 |
|
|
2021
Q2 | $772K | Buy |
+207,543
| New | +$772K | ﹤0.01% | 3896 |
|
|
2021
Q1 | – | Sell |
-55,753
| Closed | -$187K | – | 5084 |
|
|
2020
Q4 | $187K | Buy |
55,753
+26,501
| +91% | +$88.9K | ﹤0.01% | 3741 |
|
|
2020
Q3 | $103 | Sell |
29,252
-130,215
| -82% | -$458 | ﹤0.01% | 3395 |
|
|
2020
Q2 | $734K | Buy |
159,467
+61,025
| +62% | +$281K | ﹤0.01% | 2549 |
|
|
2020
Q1 | $326K | Buy |
+98,442
| New | +$326K | ﹤0.01% | 2512 |
|
|
2019
Q4 | – | Sell |
-60,146
| Closed | -$250K | – | 3908 |
|
|
2019
Q3 | $250K | Buy |
+60,146
| New | +$250K | ﹤0.01% | 3037 |
|
|
2019
Q2 | – | Sell |
-121,979
| Closed | -$1.16M | – | 3918 |
|
|
2019
Q1 | $1.16M | Sell |
121,979
-11,043
| -8% | -$105K | ﹤0.01% | 2342 |
|
|
2018
Q4 | $411K | Buy |
+133,022
| New | +$411K | ﹤0.01% | 2706 |
|